Policy / Pricing AbbVie tries a new approach in 340B programme battle PharmaphorumAbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.Policy / PricingRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaphorum AbbVie has opened a new front in the pharma industry’s efforts to reform the 340B drug discounting programme for safety net hospitals in the US. Policy / PricingRead full story Post navigation Previous: The FTC Blows Up Express Scripts’ PBM Model–and Launches the Net Pricing Drug Channel (rerun)Next: Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors Related Stories Policy / Pricing UniQure, Replimune shares rise as FDA’s Makary exits, but path forward unchanged pharminent May 13, 2026 Policy / Pricing EU agrees plan to tackle essential medicine shortages pharminent May 12, 2026 Policy / Pricing 340B in 2026: Market Shifts, Policy Battles, and What They Mean for Stakeholders (NEW Live Video Webinar) pharminent May 12, 2026
